Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
暂无分享,去创建一个
A. Haeberli | H. Baur | H. Rapold | H. Kuemmerli | M. Weiss | Hans J. Rapold | Matthias Weiss | Hans Baur | André Haeberli | A. Haeberli
[1] M. Levine,et al. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen. , 1988, The Journal of clinical investigation.
[2] K. Friedman,et al. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. , 1988, Blood.
[3] P. Lichtlen,et al. THROMBIN/ANTITHROMBIN-III COMPLEX LEVEL AS EARLY PREDICTOR OF REOCCLUSION AFTER SUCCESSFUL THROMBOLYSIS , 1988, The Lancet.
[4] J. Willerson,et al. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. , 1988, Circulation.
[5] G. FitzGerald,et al. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. , 1988, Circulation.
[6] A. Jaffe,et al. Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. , 1987, Journal of the American College of Cardiology.
[7] A. Ross,et al. Reinfarction, recurrent angina, and reocclusion after thrombolytic therapy. , 1987, Circulation.
[8] W. Steinbrunn,et al. Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease? , 1987, European heart journal.
[9] J. Gore,et al. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction. , 1987, The American journal of cardiology.
[10] C. Francis,et al. INCREASED PLASMA CONCENTRATION OF CROSSLINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL INFARCTION , 1987, Thrombosis and Haemostasis.
[11] J. Conard,et al. Theoretic and Practical Considerations on Laboratory Monitoring of Thrombolytic Therapy , 1987, Seminars in thrombosis and hemostasis.
[12] J. Soria,et al. Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarction. , 1987, Seminars in thrombosis and hemostasis.
[13] E. Topol,et al. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. , 1987, The American journal of cardiology.
[14] P. Théroux,et al. Fibrinopeptide A and platelet factor levels in unstable angina pectoris. , 1987, Circulation.
[15] C. Francis,et al. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction. , 1986, Circulation.
[16] A. Gallino,et al. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin. , 1986, American heart journal.
[17] A. Jaffe,et al. Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis. , 1986, Journal of the American College of Cardiology.
[18] F V Lucas,et al. Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation. , 1986, Circulation.
[19] I. Palacios,et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.
[20] E. Braunwald,et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. , 1986, Circulation.
[21] D. Collen,et al. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. , 1985, The Journal of pharmacology and experimental therapeutics.
[22] Paul,et al. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. , 1985, The Journal of biological chemistry.
[23] A. Gallino,et al. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia. , 1985, Circulation.
[24] A. Jaffe,et al. Fibrinopeptide A: a marker of acute coronary thrombosis. , 1985, Circulation.
[25] R. W. Brower,et al. RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator , 1985, The Lancet.
[26] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[27] D. Hoppensteadt,et al. Performance Characteristics of a Simple Radioimmunoassay for Fibrinopeptide A , 1984, Seminars in thrombosis and hemostasis.
[28] A. Haeberli,et al. Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction. , 1984, Circulation.
[29] R. Bertina,et al. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. , 1984, American heart journal.
[30] C. Francis,et al. Thrombin activity of fibrin thrombi and soluble plasmic derivatives. , 1983, The Journal of laboratory and clinical medicine.
[31] L. Johnson,et al. Exercise-induced myocardial ischemia in patients with coronary artery disease: lack of evidence for platelet activation or fibrin formation in peripheral venous blood. , 1983, Journal of the American College of Cardiology.
[32] J. Hermans,et al. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism. , 2009, Acta medica Scandinavica.
[33] P. Cannon,et al. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease. , 1982, Blood.
[34] C. Prowse,et al. Proteolysis of fibrinogen in healthy volunteers following major and minor vivo plasminogen activation. , 1982, Thrombosis research.
[35] R. Asinger,et al. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. , 1981, The New England journal of medicine.
[36] R. Abbate,et al. Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations. , 1981, American heart journal.
[37] C. Kockum. Radioimmunoassay of fibrinopeptide A - immunoreactivity of fibrinogen and fibrinogen fragments. , 1980, Thrombosis research.
[38] J. V. van Mourik,et al. Effect of anticoagulant treatment measured by fibrinopeptide A (fpA) in patients with venous thrombo-embolism. , 1980, Thrombosis research.
[39] H. Johnsson,et al. Fibrinopeptide a (FPA) in patients with acute myocardial infarction. , 1979, Thrombosis research.
[40] E. Shaw,et al. D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin. , 1979, Thrombosis research.
[41] J. Hirsh,et al. Plasma fibrinopeptide A levels in symptomatic venous thromboembolism. , 1978, Blood.
[42] P. Straub,et al. A radioimmunoassay technique for the rapid measurement of human fibrinopeptide A. , 1977, Thrombosis research.
[43] J. van der Meer,et al. Fibrinopeptide a Determination in Clinical Plasma Samples , 1977, Thrombosis and Haemostasis.
[44] H. L. Nossel. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis. , 1976, The New England journal of medicine.
[45] R. Canfield,et al. Specificity of Antisera to Human Fibrinopeptide A Used in Clinical Fibrinopeptide A Assays , 1976, Thrombosis and Haemostasis.
[46] C. Kockum. Radioimmunoassay of fibrinopeptide A-clinical applications. , 1976, Thrombosis research.
[47] R. Canfield,et al. Measurement of fibrinopeptide A in human blood. , 1974, The Journal of clinical investigation.
[48] J. Shillingford,et al. Frequency of venous thrombosis after myocardial infarction. , 1971, Lancet.
[49] A. Clauss,et al. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .
[50] F. R. Bettelheim. The clotting of fibrinogen. II. Fractionation of peptide material liberated. , 1956, Biochimica et biophysica acta.